Efficacy of Probiotics in Preventing Chemotherapy-Induced Diarrhea in Gastrointestinal Cancer Patients
Published: 6 February 2025| Version 1 | DOI: 10.17632/bgbnkcgy9k.1
Contributor:
Gabriel de SouzaDescription
In this study we aimed to evaluate the efficacy of probiotics in prevention of chemotherapy induced diarrhea among patients with gastrointestinal cancer. A total of 28 patients diagnosed with gastrointestinal cancer who were intended to receive chemotherapy based on fluoropyrimidine, oxaliplatin, and/or irinotecan were randomized in a ratio 1:1 to receive either a placebo or probiotic. Patients were instructed to take the product orally once daily for 90 days and to record their bowel habits in a diary using the Bristol stool scale. In this dataset are the collected data from the 28 recruited patients.
Files
Institutions
Universidade Federal de Sao Paulo Departamento de Medicina
Categories
Patient Data Management
Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo
#2021/12587-2